Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
28761 | 163 | 18.2 | 36% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
3164 | 1650 | IMIDAZO1 2 APYRIDINE//IMIDAZO1 2 APYRIDINES//TDAE |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | SATRANIDAZOLE | Author keyword | 4 | 47% | 4% | 7 |
2 | AROYLHYDRAZINES | Author keyword | 1 | 50% | 1% | 2 |
3 | BIOCIS CHIM THER EUT | Address | 1 | 50% | 1% | 1 |
4 | CAS 19387 91 8 | Author keyword | 1 | 50% | 1% | 1 |
5 | DEVINNOVAT MED | Address | 1 | 50% | 1% | 1 |
6 | DRUG THEORET | Address | 1 | 50% | 1% | 1 |
7 | RED BLOOD CELLS ERYTHROCYTES | Author keyword | 1 | 50% | 1% | 1 |
8 | UMR 8076 PHARM | Address | 1 | 50% | 1% | 1 |
9 | 3H | Author keyword | 0 | 33% | 1% | 1 |
10 | DEV INNOVAT MED | Address | 0 | 33% | 1% | 1 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | SATRANIDAZOLE | 4 | 47% | 4% | 7 | Search SATRANIDAZOLE | Search SATRANIDAZOLE |
2 | AROYLHYDRAZINES | 1 | 50% | 1% | 2 | Search AROYLHYDRAZINES | Search AROYLHYDRAZINES |
3 | CAS 19387 91 8 | 1 | 50% | 1% | 1 | Search CAS+19387+91+8 | Search CAS+19387+91+8 |
4 | RED BLOOD CELLS ERYTHROCYTES | 1 | 50% | 1% | 1 | Search RED+BLOOD+CELLS+ERYTHROCYTES | Search RED+BLOOD+CELLS+ERYTHROCYTES |
5 | 3H | 0 | 33% | 1% | 1 | Search 3H | Search 3H |
6 | MUSCARINIC RECEPTOR AFFINITY | 0 | 33% | 1% | 1 | Search MUSCARINIC+RECEPTOR+AFFINITY | Search MUSCARINIC+RECEPTOR+AFFINITY |
7 | PROPYLPHOSPHONIC ANHYDRIDE R T3P | 0 | 33% | 1% | 1 | Search PROPYLPHOSPHONIC+ANHYDRIDE+R+T3P | Search PROPYLPHOSPHONIC+ANHYDRIDE+R+T3P |
8 | SULFONAMIDINE | 0 | 33% | 1% | 1 | Search SULFONAMIDINE | Search SULFONAMIDINE |
9 | CREATIVE RESEARCH | 0 | 25% | 1% | 1 | Search CREATIVE+RESEARCH | Search CREATIVE+RESEARCH |
10 | Q ABSORBANCE RATIO METHOD | 0 | 25% | 1% | 1 | Search Q+ABSORBANCE+RATIO+METHOD | Search Q+ABSORBANCE+RATIO+METHOD |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | GO 10213 | 1 | 100% | 1% | 2 |
2 | ANTIIMPLANTATION AGENTS | 1 | 50% | 1% | 1 |
3 | PEDIATRIC ONCOLOGY BRANCH | 0 | 33% | 1% | 1 |
4 | LOADED ALGINATE | 0 | 25% | 1% | 1 |
5 | STABLE TRIFLUOROACETYL DERIVATIVES | 0 | 25% | 1% | 1 |
6 | CONDENSED HETEROTRICYCLES | 0 | 20% | 1% | 1 |
7 | T3P | 0 | 17% | 1% | 1 |
8 | MEDIATED CONVERSION | 0 | 13% | 1% | 1 |
9 | TUBERCULOSTATIC ACTIVITY | 0 | 11% | 1% | 1 |
10 | 4 OXO 4 5 6 7 TETRAHYDROINDOLE 3 ACETIC ACIDS | 0 | 100% | 1% | 1 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Erythrocytes and the transport of drugs and endogenous compounds | 1996 | 31 | 36 | 14% |
Theoretical aspects of rational drug design - An overview | 2001 | 4 | 57 | 11% |
Human red blood cells: Rheological aspects, uptake, and release of cytotoxic drugs | 2004 | 16 | 100 | 3% |
TO MARKET, TO MARKET - 1988 | 1989 | 8 | 59 | 7% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | BIOCIS CHIM THER EUT | 1 | 50% | 0.6% | 1 |
2 | DEVINNOVAT MED | 1 | 50% | 0.6% | 1 |
3 | DRUG THEORET | 1 | 50% | 0.6% | 1 |
4 | UMR 8076 PHARM | 1 | 50% | 0.6% | 1 |
5 | DEV INNOVAT MED | 0 | 33% | 0.6% | 1 |
6 | ISOTOPE CHEM SCREENING PROFILING GLOBAL DMPK IM | 0 | 33% | 0.6% | 1 |
7 | JVPD EME | 0 | 33% | 0.6% | 1 |
8 | CLIN PHARMACOL BIOANAL | 0 | 25% | 0.6% | 1 |
9 | SCREENING PROFILING GLOBAL DMPK IM | 0 | 25% | 0.6% | 1 |
10 | CNSP IMED SCI SODERTALJE | 0 | 20% | 0.6% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000202981 | ACID INDUCED INDOLE CYCLIZATION//22810 TAMAGAWA SETAGAYA KU//DECARBOXYLATIVE CYCLIZATION |
2 | 0.0000195667 | MED MEANS CHEM//EMIZCO//P NITROACETOPHENONE |
3 | 0.0000116801 | TDAE//PHARMACOCHIM RADICALAIRE//CNRSUMR 6264 CHIM PROVENCE |
4 | 0.0000108129 | FLEXIMERS//4 METHYL BENZENESUFONYL CHLORIDE//INDOLE NUCLEOSIDE |
5 | 0.0000099409 | 1 4 ADDUCTS//BENZOFURAN 3 ONES//COPPER CATALYZED CASCADE ADDITION |
6 | 0.0000094698 | 1 4 PYRAZOLYL TRANSFER//PYRAZOLO3 4 CISOTHIAZOLE//SECT BOT GARDEN |
7 | 0.0000085460 | CINNOLINE//CINNOLINES//COARCTATE |
8 | 0.0000084172 | METRONIDAZOLE//TINIDAZOLE//NITROIMIDAZOLES |
9 | 0.0000080697 | NITAZOXANIDE//TIZOXANIDE//HEPATOL GASTROENTEROL INFECT DIS |
10 | 0.0000076807 | KETOENAMINES//INDOLINOSPIROPYRANS//ESS ANALYSIS OF ELECTRONIC EXCITATIONS |